Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate

Published:2009-09-30 Issue:3 Volume:3 Page:205-210
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut Liver

Author:

Chang Jae Hyuck,Lee In Seok,Kim Hyung Keun,Cho Yu Kyung,Park Jae Myung,Kim Sang Woo,Choi Myung-Gyu,Chung In-Sik

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2009/003/gnl-3-205.pdf

Reference23 articles.

1. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study

2. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial

3. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials

4. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography

5. Indomethacin May Reduce the Incidence and Severity of Acute Pancreatitis After ERCP

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Listeria Monocytogenes HtrA Protease with Camostat, Gabexate and Nafamostat Mesylates and the Binding Mode of the Inhibitors;The Protein Journal;2023-04-24

2. Repurposed Drugs Against SARS-CoV-2 Replication in COVID-19;Drug Repurposing Against SARS-CoV-2;2023-04-12

3. Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics;Annual Review of Pharmacology and Toxicology;2021-01-06

4. A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2;EMBO Molecular Medicine;2020-11-03

5. Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies;Molecules;2020-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3